SPROUT SOLUTIONS
Live / Applied — Second extension granted (statement of use) (as of 02 Mar 2026)
What this means for you
Not registered yet, but its 02 Apr 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98480408
- Mark type
- Stylized text
- Filed
- 02 Apr 2024
- Published for opposition
- 07 Jan 2025
- Attorney of record
- Susan M. Natland
Goods and services
- Class 040 — Treatment of materials: Custom manufacturing of pharmaceuticals, biological preparations, chemical preparations, and reagents for others; biomanufacturing for others, namely, manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process; biomanufacturing platforms for others, namely, platforms for manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process; consulting services in the field of manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; custom processing and manufacture of vectors, cells and proteins for use in the field of biotechnology, being, biomanufacturing for others
- Class 042 — Scientific and technological services: Research, development, and consulting services related thereto in the field of manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; genetic engineering services, namely, research in the field of genetics; biotechnology research and development; scientific, pharmaceutical, and medical research services relating to in the field of biological treatment and bioproduction; providing scientific research information, namely, the provision of information for relating to research and development of biopharmaceuticals that are manufactured using biological treatment and bioproduction platforms development of new technology for others in the field of biotechnology, biomanufacturing, and pharmaceuticals; new product design services; biotechnology design services relating to for the creation of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; providing scientific research information, namely, the preparation of reports relating to biomanufacturing and manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins
Owner
- NATIONAL RESILIENCE, LLC, BLUE ASH, OH, US
- National Resilience, Inc., San Diego, CA, US
- National Resilience, Inc., La Jolla, CA, US
Prosecution history
- 03 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Mar 2026 — SOU EXTENSION 2 GRANTED
- 02 Mar 2026 — SOU EXTENSION 2 FILED
- 02 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 11 Feb 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 11 Feb 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 11 Feb 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 11 Feb 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 Feb 2026 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 21 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Aug 2025 — SOU EXTENSION 1 GRANTED
- 19 Aug 2025 — SOU EXTENSION 1 FILED
- 19 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 04 Mar 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED